Institute Of Biomedical Stock Current Valuation
| MRES Stock | USD 0.01 0.0006 7.50% |
Valuation analysis of Institute of Biomedical helps investors to measure Institute's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Institute's price fluctuation is out of control at this time. Calculation of the real value of Institute of Biomedical is based on 3 months time horizon. Increasing Institute's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Institute pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Institute of Biomedical. Since Institute is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Institute Pink Sheet. However, Institute's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0074 | Real 0.006783 | Hype 0.01 | Naive 0.006314 |
The intrinsic value of Institute's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Institute's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Institute of Biomedical helps investors to forecast how Institute pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Institute more accurately as focusing exclusively on Institute's fundamentals will not take into account other important factors: Institute of Biomedical Company Current Valuation Analysis
Institute's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Institute Current Valuation | 198.84 K |
Most of Institute's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Institute of Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Institute of Biomedical has a Current Valuation of 198.84 K. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Institute Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Institute's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Institute could also be used in its relative valuation, which is a method of valuing Institute by comparing valuation metrics of similar companies.Institute is currently under evaluation in current valuation category among its peers.
Institute Fundamentals
| Current Valuation | 198.84 K | |||
| Shares Outstanding | 66.28 M | |||
| Price To Book | 0.69 X | |||
| Revenue | 1.41 M | |||
| Net Income | 564.67 K | |||
| Cash Flow From Operations | 2.06 M | |||
| Beta | 1.71 | |||
| Market Capitalization | 639.61 K | |||
| Total Asset | 5.28 M | |||
| Retained Earnings | (55.58 M) | |||
| Current Asset | 2.56 M | |||
| Current Liabilities | 3.8 M | |||
| Z Score | -14.0 | |||
| Net Asset | 5.28 M |
About Institute Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Institute of Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Institute using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Institute of Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Institute Pink Sheet Analysis
When running Institute's price analysis, check to measure Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Institute is operating at the current time. Most of Institute's value examination focuses on studying past and present price action to predict the probability of Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Institute's price. Additionally, you may evaluate how the addition of Institute to your portfolios can decrease your overall portfolio volatility.